Inflammation-nutrition score predicts response to neoadjuvant therapy in rectal cancer

▸ TREATMENT

In 312 patients with locally advanced rectal cancer, a low pretreatment inflammation-nutrition prognostic score (INPS) was independently associated with higher response rates (61% vs. 29%) and pathological complete response (39% vs. 12%), outperforming PD-L1 testing alone. (Front Genet)